Brain Stimulation for Neurological Patients

Brain Stimulation for Neurological Patients

This is a prospective double-blind randomized placebo-controlled crossover clinical trial

Inclusion Criteria:

• Clinically stable patients with probable Alzheimer's Disease (Diagnosis according to ICD-10 Criteria (F00))
• At least 3 months of stable antidementive therapy or no antidementive therapy necessary
• Signed written informed consent
• Monthly pregnancy test for women in childbearing years
• Age >= 18 years

Exclusion Criteria:

• Non-compliance with the protocol
• Pregnant or breastfeeding women
• Relevant intracerebral pathology unrelated to the Alzheimers's disease (e.g. Brain tumor)
• Hemophilia or other blood clotting disorders
• Cortisone treatment within the last 6 weeks before first treatment
• Thrombosis